First-time shopping offerGet 35% OFF on your first eligible order
Lisinopril Tablets IP 1 image Best Seller
Request Quote
✓Secured TradingProtected supplier enquiry
Verified supplier

Lisinopril Tablets IP

★ 2 64 reviews Ready stock
Category: Antihypertensive Drugs
Pricing Get Latest Price 10 Strip minimum order
Aim Global Alliance Sold by Aim Global Alliance Nagpur, Maharashtra ✓ Verified Supplier
3.1/5 ★★★☆☆ 14,771 Ratings 151 active listings
PRODUCT FEEDBACK

Ratings & reviews

64 ratings
2.0★out of 5
Buyer rating★★☆☆☆Based on verified marketplace rating data
Seller experience3.1/514,771 supplier ratings
Secure TransactionSafe & secure enquiry
Fast & ReliableDirect supplier response
Quality AssuredVerified seller profile
Dedicated SupportHelp when you need it
Secure payment optionsAvailable on eligible direct orders
UPI GPay PhonePe VISA ●●Cards ▣Net Banking
Secure checkout on eligible products
PRODUCT DETAILS

Everything you need before you source

Review overview, specifications and supplier information in one clear product workspace.

Buyer-ready information
PRODUCT OVERVIEW

Lisinopril Tablets IP

Lisinopril Tablets IP are prescribed to treat high blood pressure (hypertension), heart failure, and to improve survival after a heart attack. As an ACE inhibitor (angiotensin-converting enzyme inhibitor), lisinopril works by relaxing blood vessels, making it easier for the heart to pump blood. This helps lower blood pressure and reduce the risk of stroke and heart attack. Typically taken once daily, Lisinopril can cause side effects like dizziness, cough, and headache. In rare cases, it may lead to serious conditions like kidney issues or high potassium levels. It's important to follow your doctor's dosage instructions and have regular check-ups to monitor your health while on this medication.
Direct supplier enquiryYour requirement goes straight to the listed supplier.
Commercial clarityConfirm quantity, specification, lead time and delivery before ordering.
Buyer-ready sourcingNo payment is required to request the latest quotation.